Vipr1 Protein

Vipr1 Protein

Introduction

The Vipr1 protein (Vasoactive Intestinal Peptide Receptor 1) is a Secretin receptor family (Class B GPCR) member involved in Receptor for vasoactive intestinal peptide (VIP), involved in neuroprotection, immune modulation, and circadian rhythm regulation. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@vipr]
<table> [@vipra]
<tr><th colspan="2" style="background-color: #e65100; color: white;">Vipr1 (Vasoactive Intestinal Peptide Receptor 1)</th></tr> [@therapeutic]
<tr><td><strong>Official Symbol</strong></td><td>Vipr1</td></tr> [@viprb]
<tr><td><strong>Gene</strong></td><td>VIPR1</td></tr> [@gpcr]
<tr><td><strong>Chromosomal Location</strong></td><td>3p22.1</td></tr> [@viprc]
<tr><td><strong>UniProt ID</strong></td><td>P32246</td></tr> [@clinical]
<tr><td><strong>Molecular Weight</strong></td><td>~50 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane (GPCR)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Secretin receptor family (Class B GPCR)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>

Overview

Receptor for vasoactive intestinal peptide (VIP), involved in neuroprotection, immune modulation, and circadian rhythm regulation. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.

Normal Function

Vipr1 Protein

Introduction

The Vipr1 protein (Vasoactive Intestinal Peptide Receptor 1) is a Secretin receptor family (Class B GPCR) member involved in Receptor for vasoactive intestinal peptide (VIP), involved in neuroprotection, immune modulation, and circadian rhythm regulation. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@vipr]
<table> [@vipra]
<tr><th colspan="2" style="background-color: #e65100; color: white;">Vipr1 (Vasoactive Intestinal Peptide Receptor 1)</th></tr> [@therapeutic]
<tr><td><strong>Official Symbol</strong></td><td>Vipr1</td></tr> [@viprb]
<tr><td><strong>Gene</strong></td><td>VIPR1</td></tr> [@gpcr]
<tr><td><strong>Chromosomal Location</strong></td><td>3p22.1</td></tr> [@viprc]
<tr><td><strong>UniProt ID</strong></td><td>P32246</td></tr> [@clinical]
<tr><td><strong>Molecular Weight</strong></td><td>~50 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane (GPCR)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Secretin receptor family (Class B GPCR)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>

Overview

Receptor for vasoactive intestinal peptide (VIP), involved in neuroprotection, immune modulation, and circadian rhythm regulation. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.

Normal Function

Signaling Pathways

Vipr1 participates in key signaling cascades:

• G-protein coupled receptor signaling (for GPCR family members)
• Calcium signaling
• cAMP/PKA pathway modulation
• MAPK/ERK pathway activation

Physiological Roles

Receptor for vasoactive intestinal peptide (VIP), involved in neuroprotection, immune modulation, and circadian rhythm regulation. In the central nervous system, this protein:

• Modulates neurotransmitter release
• Regulates neuronal excitability
• Influences neuroimmune interactions
• Affects circadian rhythm mechanisms

Protein Structure

Domains

• Extracellular domain: Ligand binding
• Transmembrane domains: 7TM architecture (for GPCR family)
• Intracellular domain: G-protein coupling and signaling

Post-translational Modifications

• N-glycosylation: Affects ligand binding and trafficking
• Phosphorylation: Modulates receptor activity
• Palmitoylation: Affects membrane localization

Disease Associations

Alzheimer's Disease

Vipr1 is implicated in Alzheimer's disease through:

• [Neuroinflammation](/mechanisms/neuroinflammation-neurodegeneration) modulation
• [Amyloid](/mechanisms/amyloid-cascade-pathway) interactions
• [Tau](/mechanisms/tau-pathology) pathology involvement
• Synaptic function regulation

Parkinson's Disease

In Parkinson's disease:

• Dopaminergic signaling modulation
• [Neuroinflammation](/mechanisms/neuroinflammation-neurodegeneration) response
• Mitochondrial function effects

Neuroimmune Interactions

Vipr1 plays a role in:

• Microglial activation states
• Peripheral immune-brain communication
• Inflammatory cytokine regulation

Therapeutic Implications

Drug Targets

Vipr1 is being investigated as a therapeutic target:

• Agonists: Enhancing neuroprotective signaling
• Antagonists: Modulating pathological immune activation
• Allosteric modulators: Fine-tuning receptor activity

Clinical Applications

• Biomarker potential for neuroinflammation
• Patient stratification markers
• Therapeutic monitoring endpoints

Interactions

Molecular Partners

Vipr1 interacts with:

• [Neuroinflammation pathway](/mechanisms/neuroinflammation-neurodegeneration)
• [Synaptic dysfunction pathway](/mechanisms/synaptic-dysfunction-neurodegeneration)
• [Mitochondrial dysfunction pathway](/mechanisms/mitochondrial-dysfunction-parkinsons)
• [Circadian clock pathway](/mechanisms/circadian-clock-pathway)

Signaling Cascades

• G-protein mediated signaling
• Calcium homeostasis
• cAMP signaling
• MAPK/ERK pathway

See Also

• [VIPR1 Gene](/genes/vipr1)
• [Proteins Index](/proteins)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-neurodegeneration)
• [GPCR Signaling in Neurodegeneration](/mechanisms)

External Links

• [UniProt: P32246](https://www.uniprot.org/uniprot/P32246)
• [NCBI Gene: VIPR1](https://www.ncbi.nlm.nih.gov/gene/)
• [Protein Data Bank: Vipr1](https://www.rcsb.org/)
• [GeneCards: Vipr1](https://www.genecards.org/)

Background

The study of Vipr1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References